PubRank

J S Pober

Author PubWeight™ 261.91‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci U S A 1987 10.43
2 Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. J Clin Invest 1985 8.70
3 Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J Immunol 1986 8.22
4 Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998 7.70
5 Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med 1984 5.89
6 Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. Proc Natl Acad Sci U S A 1986 5.83
7 Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells. J Immunol 1986 5.57
8 Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A,B antigens in vascular endothelial cells and dermal fibroblasts in vitro. Proc Natl Acad Sci U S A 1986 5.03
9 Ia expression by vascular endothelium is inducible by activated T cells and by human gamma interferon. J Exp Med 1983 4.92
10 Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts. Proc Natl Acad Sci U S A 1984 4.43
11 Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon. Nature 1983 4.16
12 Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. Science 2000 4.04
13 Induction and detection of a human endothelial activation antigen in vivo. J Exp Med 1986 3.66
14 Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE. Am J Pathol 1990 3.26
15 Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species. J Immunol 1987 3.06
16 Tumor necrosis factor receptor-associated factors (TRAFs). Oncogene 2001 2.98
17 Recombinant tumor necrosis factor and immune interferon act singly and in combination to reorganize human vascular endothelial cell monolayers. Am J Pathol 1986 2.95
18 Cultured human endothelial cells express platelet-derived growth factor B chain: cDNA cloning and structural analysis. Nature 1985 2.87
19 Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease. Lancet 1989 2.86
20 Tumor necrosis factor and interferon-gamma induce distinct patterns of endothelial activation and associated leukocyte accumulation in skin of Papio anubis. Am J Pathol 1989 2.72
21 Adhesion of human B cells to germinal centers in vitro involves VLA-4 and INCAM-110. Science 1990 2.69
22 In vivo formation of complex microvessels lined by human endothelial cells in an immunodeficient mouse. Proc Natl Acad Sci U S A 2000 2.67
23 Interleukin-1 activation of vascular endothelium. Effects on procoagulant activity and leukocyte adhesion. Am J Pathol 1985 2.59
24 Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci U S A 1997 2.56
25 Interferon-gamma elicits arteriosclerosis in the absence of leukocytes. Nature 2000 2.55
26 Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation 1997 2.12
27 Control of apoptosis during angiogenesis by survivin expression in endothelial cells. Am J Pathol 2000 2.10
28 CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc Natl Acad Sci U S A 1995 1.99
29 Chronic rejection. Immunity 2001 1.98
30 Effects of tumor necrosis factor, lipopolysaccharide, and IL-4 on the expression of vascular cell adhesion molecule-1 in vivo. Correlation with CD3+ T cell infiltration. J Immunol 1992 1.96
31 Expression of Ia-like antigens by human vascular endothelial cells is inducible in vitro: demonstration by monoclonal antibody binding and immunoprecipitation. Proc Natl Acad Sci U S A 1982 1.87
32 Membrane interleukin 1 induction on human endothelial cells and dermal fibroblasts. J Immunol 1987 1.86
33 Human coronary transplantation-associated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells. Am J Pathol 1991 1.82
34 Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon. J Clin Invest 1986 1.81
35 TNF signaling in vascular endothelial cells. Exp Mol Pathol 2001 1.78
36 Heterogeneity of dermal microvascular endothelial cell antigen expression and cytokine responsiveness in situ and in cell culture. J Immunol 1993 1.78
37 Three distinct classes of regulatory cytokines control endothelial cell MHC antigen expression. Interactions with immune gamma interferon differentiate the effects of tumor necrosis factor and lymphotoxin from those of leukocyte alpha and fibroblast beta interferons. J Exp Med 1988 1.76
38 Human cytolytic T lymphocyte interactions with vascular endothelium and fibroblasts: role of effector and target cell molecules. J Immunol 1984 1.75
39 Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome. J Exp Med 1986 1.74
40 Inducible expression of class II major histocompatibility complex antigens and the immunogenicity of vascular endothelium. Transplantation 1986 1.64
41 Induced expression of endothelial-leukocyte adhesion molecules in human cardiac allografts. Transplantation 1991 1.62
42 IFN-gamma enhances endothelial activation induced by tumor necrosis factor but not IL-1. J Immunol 1990 1.56
43 Interleukin-4 induces the synthesis and secretion of MCP-1/JE by human endothelial cells. Am J Pathol 1991 1.55
44 Composition of the von Willebrand factor storage organelle (Weibel-Palade body) isolated from cultured human umbilical vein endothelial cells. J Cell Biol 1987 1.53
45 Phosphorylation in vivo and in vitro of human histocompatibility antigens (HLA-A and HLA-B) in the carboxy-terminal intracellular domain. Proc Natl Acad Sci U S A 1978 1.50
46 TNF recruits TRADD to the plasma membrane but not the trans-Golgi network, the principal subcellular location of TNF-R1. J Immunol 1999 1.47
47 Light-regulated enzymes of vertebrate retinal rods. Adv Cyclic Nucleotide Res 1979 1.47
48 Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. Elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity. J Clin Invest 1994 1.46
49 A phosphatidylinositol 3-kinase/Akt pathway, activated by tumor necrosis factor or interleukin-1, inhibits apoptosis but does not activate NFkappaB in human endothelial cells. J Biol Chem 2000 1.46
50 Induction of an activation antigen on postcapillary venular endothelium in human skin organ culture. J Immunol 1987 1.44
51 Cultured human endothelial cells express platelet-derived growth factor A chain. Am J Pathol 1987 1.42
52 Functions of vascular wall cells related to development of transplantation-associated coronary arteriosclerosis. Transplant Proc 1989 1.40
53 Effects of cytokines on vascular endothelium: their role in vascular and immune injury. Kidney Int 1989 1.38
54 Human T-cell-mediated destruction of allogeneic dermal microvessels in a severe combined immunodeficient mouse. Proc Natl Acad Sci U S A 1994 1.36
55 Lytic anti-endothelial cell antibodies in haemolytic-uraemic syndrome. Lancet 1988 1.33
56 TNF initiates E-selectin transcription in human endothelial cells through parallel TRAF-NF-kappa B and TRAF-RAC/CDC42-JNK-c-Jun/ATF2 pathways. J Immunol 1997 1.31
57 Endothelial cells augment T cell interleukin 2 production by a contact-dependent mechanism involving CD2/LFA-3 interaction. J Exp Med 1990 1.30
58 Large-scale culture and selective maturation of human Langerhans cells from granulocyte colony-stimulating factor-mobilized CD34+ progenitors. J Immunol 2000 1.30
59 Endothelial activation during interleukin 2 immunotherapy. A possible mechanism for the vascular leak syndrome. J Immunol 1988 1.30
60 Antigen-presenting function of human endothelial cells. Direct activation of resting CD8 T cells. J Immunol 1994 1.29
61 Tumor necrosis factor and immune interferon synergistically increase transcription of HLA class I heavy- and light-chain genes in vascular endothelium. Proc Natl Acad Sci U S A 1990 1.29
62 Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting. Am J Pathol 2001 1.27
63 Recruitment of neutrophils in the local endotoxin response: association with de novo endothelial expression of endothelial leukocyte adhesion molecule-1. Lab Invest 1991 1.26
64 Expression of tumor necrosis factor receptors in normal kidney and rejecting renal transplants. Lab Invest 2001 1.25
65 Expression of endothelial-leukocyte adhesion molecule-1 in elicited late phase allergic reactions. J Clin Invest 1991 1.25
66 Tumor necrosis factor activates human endothelial cells through the p55 tumor necrosis factor receptor but the p75 receptor contributes to activation at low tumor necrosis factor concentration. Am J Pathol 1993 1.23
67 Caveolin-1 associates with TRAF2 to form a complex that is recruited to tumor necrosis factor receptors. J Biol Chem 2000 1.22
68 Blockade of CD2-LFA-3 interactions protects human skin allografts in immunodeficient mouse/human chimeras. Nat Biotechnol 1997 1.20
69 Cytokine-endothelial interactions in inflammation, immunity, and vascular injury. J Am Soc Nephrol 1990 1.20
70 Disparate localization of 55-kd and 75-kd tumor necrosis factor receptors in human endothelial cells. Am J Pathol 1995 1.18
71 Ceramide is not a signal for tumor necrosis factor-induced gene expression but does cause programmed cell death in human vascular endothelial cells. Circ Res 1996 1.18
72 The endothelial cell as a regulator of T-cell function. Immunol Rev 1990 1.16
73 Transcriptional regulation of the interleukin-2 gene in normal human peripheral blood T cells. Convergence of costimulatory signals and differences from transformed T cells. J Biol Chem 1996 1.15
74 IL-4 and IL-13 activate the JAK2 tyrosine kinase and Stat6 in cultured human vascular endothelial cells through a common pathway that does not involve the gamma c chain. J Clin Invest 1996 1.14
75 Human endothelial cells effectively costimulate cytokine production by, but not differentiation of, naive CD4+ T cells. J Immunol 1998 1.13
76 Antibody-mediated aplastic anemia and diffuse fasciitis. N Engl J Med 1979 1.13
77 cAMP and tumor necrosis factor competitively regulate transcriptional activation through and nuclear factor binding to the cAMP-responsive element/activating transcription factor element of the endothelial leukocyte adhesion molecule-1 (E-selectin) promoter. J Biol Chem 1994 1.13
78 Interleukin-11 up-regulates survivin expression in endothelial cells through a signal transducer and activator of transcription-3 pathway. Lab Invest 2001 1.13
79 Human CD4+ T cells proliferate to HLA-DR+ allogeneic vascular endothelium. Identification of accessory interactions. Transplantation 1993 1.12
80 HLA class I heavy-chain gene promoter elements mediating synergy between tumor necrosis factor and interferons. Mol Cell Biol 1994 1.11
81 Identification of a novel high molecular weight protein preferentially expressed by sinusoidal endothelial cells in normal human tissues. J Cell Biol 1991 1.11
82 Interferon-gamma rapidly increases peptide transporter (TAP) subunit expression and peptide transport capacity in endothelial cells. J Biol Chem 1997 1.10
83 The N-terminal domains target TNF receptor-associated factor-2 to the nucleus and display transcriptional regulatory activity. J Immunol 1998 1.10
84 Evidence that tumor necrosis factor triggers apoptosis in human endothelial cells by interleukin-1-converting enzyme-like protease-dependent and -independent pathways. Lab Invest 1997 1.09
85 Effects of recombinant gamma-interferon on HLA-DR and DQ expression by skin cells in short-term organ culture. Lab Invest 1988 1.09
86 Purification of HLA-A2 antigen, fluorescent labeling of its intracellular region, and demonstration of an interaction between fluorescently labeled HLA-A2 antigen and lymphoblastoid cell cytoskeleton proteins in vitro. Biochemistry 1981 1.09
87 Four different classes of inhibitors of receptor-mediated endocytosis decrease tumor necrosis factor-induced gene expression in human endothelial cells. J Immunol 1993 1.08
88 Human vascular smooth muscle cells poorly co-stimulate and actively inhibit allogeneic CD4+ T cell proliferation in vitro. J Immunol 1995 1.08
89 Cytoprotection of human umbilical vein endothelial cells against apoptosis and CTL-mediated lysis provided by caspase-resistant Bcl-2 without alterations in growth or activation responses. J Immunol 2000 1.08
90 Recent advances in the molecular basis of TNF signal transduction. Lab Invest 1999 1.08
91 Human allogeneic vascular rejection after arterial transplantation and peripheral lymphoid reconstitution in severe combined immunodeficient mice. Transplantation 1999 1.07
92 Endothelial cell lymphocyte function-associated antigen-3 and an unidentified ligand act in concert to provide costimulation to human peripheral blood CD4+ T cells. Cell Immunol 1991 1.07
93 Kinetically coordinated induction of TAP1 and HLA class I by IFN-gamma: the rapid induction of TAP1 by IFN-gamma is mediated by Stat1 alpha. J Immunol 1996 1.07
94 Endothelial activation by hydrogen peroxide. Selective increases of intercellular adhesion molecule-1 and major histocompatibility complex class I. Am J Pathol 1993 1.06
95 Expression of endothelial leukocyte adhesion molecule-1 in septic but not traumatic/hypovolemic shock in the baboon. Am J Pathol 1991 1.05
96 Tumor necrosis factor alpha increases human cerebral endothelial cell Gb3 and sensitivity to Shiga toxin. Infect Immun 2001 1.05
97 Activation and homologous desensitization of human endothelial cells by CD40 ligand, tumor necrosis factor, and interleukin 1. J Exp Med 1996 1.03
98 Porcine aortic endothelial cells activate human T cells: direct presentation of MHC antigens and costimulation by ligands for human CD2 and CD28. Immunity 1994 1.03
99 Interactions of T lymphocytes with human vascular endothelial cells: role of endothelial cells surface antigens. Immunobiology 1984 1.03
100 Human vascular endothelial cells stimulate memory but not naive CD8+ T cells to differentiate into CTL retaining an early activation phenotype. J Immunol 2000 1.03
101 IL-8 and angiogenesis: evidence that human endothelial cells lack receptors and do not respond to IL-8 in vitro. Cytokine 1995 1.02
102 Mechanism of sustained E-selectin expression in cultured human dermal microvascular endothelial cells. J Immunol 1997 1.02
103 Cytokines increase transporter in antigen processing-1 expression more rapidly than HLA class I expression in endothelial cells. J Immunol 1992 1.02
104 Selective labelling of the hydrophobic segments of intrinsic membrane proteins with a lipophilic photogenerated carbene. Nature 1979 1.00
105 Tumor necrosis factor induction of endothelial cell surface antigens is independent of protein kinase C activation or inactivation. Studies with phorbol myristate acetate and staurosporine. J Immunol 1991 0.99
106 Cytoplasmic transfer between endothelium and lymphocytes: quantitation by flow cytometry. Am J Pathol 1988 0.99
107 Initial evaluation of the use of USPIO cell labeling and noninvasive MR monitoring of human tissue-engineered vascular grafts in vivo. FASEB J 2008 0.99
108 Human dermal fibroblasts present tetanus toxoid antigen to antigen-specific T cell clones. J Clin Invest 1985 0.99
109 A sustained reduction in IkappaB-beta may contribute to persistent NF-kappaB activation in human endothelial cells. J Biol Chem 1996 0.98
110 Prolonged peak elevations in cytoplasmic free calcium ions, derived from intracellular stores, correlate with the extent of thrombin-stimulated exocytosis in single human umbilical vein endothelial cells. J Cell Physiol 1994 0.98
111 Calcium/calmodulin transduces thrombin-stimulated secretion: studies in intact and minimally permeabilized human umbilical vein endothelial cells. J Cell Biol 1992 0.98
112 Apoptosis-inducing agents cause rapid shedding of tumor necrosis factor receptor 1 (TNFR1). A nonpharmacological explanation for inhibition of TNF-mediated activation. J Biol Chem 1999 0.97
113 Lymphocyte-mediated activation of cultured endothelial cells (EC). CD4+ T cells inhibit EC class II MHC expression despite secreting IFN-gamma and increasing EC class I MHC and intercellular adhesion molecule-1 expression. J Immunol 1990 0.97
114 Transglutaminase-catalyzed insertion of a fluorescent probe into the protease-sensitive region of rhodopsin. Biochemistry 1978 0.96
115 Tumor necrosis factor is delivered to mitochondria where a tumor necrosis factor-binding protein is localized. Lab Invest 1998 0.95
116 TNF receptors differentially signal and are differentially expressed and regulated in the human heart. Am J Transplant 2009 0.94
117 Porcine endothelial CD86 is a major costimulator of xenogeneic human T cells: cloning, sequencing, and functional expression in human endothelial cells. J Immunol 1996 0.94
118 Letter to the editor: Light dissociates enzymatically-cleaved rhodopsin into two different fragments. J Mol Biol 1975 0.93
119 Hydrogen peroxide-induced endothelial retraction is accompanied by a loss of the normal spatial organization of endothelial cell adhesion molecules. Am J Pathol 1995 0.93
120 Human endothelial cells augment early CD40 ligand expression in activated CD4+ T cells through LFA-3-mediated stabilization of mRNA. J Immunol 1999 0.91
121 Dermal microvascular injury in the human peripheral blood lymphocyte reconstituted-severe combined immunodeficient (HuPBL-SCID) mouse/skin allograft model is T cell mediated and inhibited by a combination of cyclosporine and rapamycin. Am J Pathol 1998 0.91
122 Tumor necrosis factor and immune interferon act in concert to slow the lateral diffusion of proteins and lipids in human endothelial cell membranes. J Cell Biol 1988 0.91
123 "Cytosolic" phospholipase A2 is in the nucleus of subconfluent endothelial cells but confined to the cytoplasm of confluent endothelial cells and redistributes to the nuclear envelope and cell junctions upon histamine stimulation. Lab Invest 1996 0.91
124 Class I major histocompatibility complex proteins diffuse isotropically on immune interferon-activated endothelial cells despite anisotropic cell shape and cytoskeletal organization: application of fluorescence photobleaching recovery with an elliptical beam. Proc Natl Acad Sci U S A 1988 0.89
125 IL-4 induction of VCAM-1 on endothelial cells involves activation of a protein tyrosine kinase. J Immunol 1995 0.89
126 The death domain of tumor necrosis factor receptor 1 is necessary but not sufficient for Golgi retention of the receptor and mediates receptor desensitization. Lab Invest 2000 0.88
127 Transglutaminase modifies the carboxy-terminal intracellular region of HLA-A and -B antigens. Nature 1981 0.88
128 Inducibility and expression of microvascular endothelial adhesion molecules in lesional, perilesional, and uninvolved skin of psoriatic patients. J Invest Dermatol 1994 0.88
129 Predictive value of inducible endothelial cell adhesion molecule expression for acute rejection of human cardiac allografts. Transplantation 1995 0.87
130 Costimulation of peripheral blood T cell activation by human endothelial cells. Enhanced IL-2 transcription correlates with increased c-fos synthesis and increased Fos content of AP-1. J Immunol 1993 0.86
131 Integrins alpha4beta7 and alphaEbeta7 are expressed on epidermotropic T cells in cutaneous T cell lymphoma and spongiotic dermatitis. Lab Invest 1999 0.86
132 Human vascular endothelial cells stimulate a lower frequency of alloreactive CD8+ pre-CTL and induce less clonal expansion than matching B lymphoblastoid cells: development of a novel limiting dilution analysis method based on CFSE labeling of lymphocytes. J Immunol 2001 0.86
133 Prolonged cytokine exposure causes a dynamic redistribution of endothelial cell adhesion molecules to intercellular junctions. Lab Invest 1996 0.86
134 Variability among human umbilical vein endothelial cultures. Science 1995 0.86
135 Transforming growth factor beta expression by human vascular cells inhibits interferon gamma production and arterial media injury by alloreactive memory T cells. Am J Transplant 2011 0.86
136 Human vascular endothelial cells favor clonal expansion of unusual alloreactive CTL. J Immunol 1999 0.86
137 IL-1 and related cytokines enhance thrombin-stimulated PGI2 production in cultured endothelial cells without affecting thrombin-stimulated von Willebrand factor secretion or platelet-activating factor biosynthesis. J Immunol 1989 0.86
138 Human endothelial cells induce and regulate cytolytic T cell differentiation. J Immunol 1998 0.85
139 Interferon induction of TAP1: the phosphatase SHP-1 regulates crossover between the IFN-alpha/beta and the IFN-gamma signal-transduction pathways. Circ Res 1998 0.85
140 Endothelial cells augment the expression of CD40 ligand on newly activated human CD4+ T cells through a CD2/LFA-3 signaling pathway. Eur J Immunol 1996 0.85
141 In vitro self-assembly of human pericyte-supported endothelial microvessels in three-dimensional coculture: a simple model for interrogating endothelial-pericyte interactions. J Vasc Res 2013 0.85
142 IL-11 activates human endothelial cells to resist immune-mediated injury. J Immunol 2000 0.85
143 Human T cells infiltrate and injure pig coronary artery grafts with activated but not quiescent endothelium in immunodeficient mouse hosts. Transplantation 2001 0.84
144 Thrombin and histamine rapidly stimulate the phosphorylation of the myristoylated alanine-rich C-kinase substrate in human umbilical vein endothelial cells: evidence for distinct patterns of protein kinase activation. J Cell Physiol 1992 0.83
145 Vascular endothelial cells enhance T cell responses by markedly augmenting IL-2 concentrations. Cell Immunol 1989 0.82
146 MS-1 sinusoidal endothelial antigen is expressed by factor XIIIa+, HLA-DR+ dermal perivascular dendritic cells. Lab Invest 1991 0.82
147 Immortalization of human endothelial cells by murine sarcoma viruses, without morphologic transformation. J Cell Physiol 1988 0.82
148 Molecular studies of von Willebrand disease: reduced von Willebrand factor biosynthesis, storage, and release in endothelial cells derived from patients with type I von Willebrand disease. Blood 1990 0.81
149 Generation of NO by bystander human CD8 T cells augments allogeneic responses by inhibiting cytokine deprivation-induced cell death. Am J Transplant 2009 0.81
150 Combining altered levels of effector transcripts in circulating T cells with a marker of endothelial injury is specific for active graft-versus-host disease. Bone Marrow Transplant 2003 0.81
151 Immunopathology of coronary arteriosclerosis in transplanted hearts. J Heart Lung Transplant 1992 0.81
152 Endothelial cell-induced resistance to cyclosporin A in human peripheral blood T cells requires contact-dependent interactions involving CD2 but not CD28. J Immunol 1994 0.81
153 Pig but not human interferon-gamma initiates human cell-mediated rejection of pig tissue in vivo. Proc Natl Acad Sci U S A 1997 0.80
154 Human TNF can induce nonspecific inflammatory and human immune-mediated microvascular injury of pig skin xenografts in immunodeficient mouse hosts. J Immunol 2000 0.79
155 Endothelial activation in the pathogenesis of Kawasaki disease. Trans Assoc Am Physicians 1989 0.79
156 Cellular and molecular biology of cardiac transplant rejection. J Nucl Cardiol 2000 0.78
157 Expression of vascular cell adhesion molecule-1 in human renal allografts. J Am Soc Nephrol 1992 0.78
158 Tumour necrosis factor is trafficked to a mitochondrial tumour necrosis factor binding protein. Biochem Soc Trans 1998 0.76
159 Endothelial cell activation by tumor necrosis factor elicits human antiporcine cell-mediated rejection responses. Transplant Proc 2001 0.75
160 Complete primary structure of human histocompatibility antigen HLA-B7: evolutionary and functional implications. Curr Top Dev Biol 1980 0.75
161 Arteriosclerosis in transplanted hearts: too much and too soon. Can J Cardiol 1991 0.75
162 Unsensitized human T cells do not infiltrate or injure quiescent pig coronary artery grafts in immunodeficient mouse hosts. Transplant Proc 2001 0.75
163 A pilot study of soluble adhesion molecules as surrogate markers for acute liver allograft rejection. Transplantation 1998 0.75
164 Tumor necrosis factor regulation of major histocompatibility complex gene expression. Immunol Res 1991 0.75
165 Proteolysis of rhodopsin. Methods Enzymol 1982 0.75